BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park TJ, Kim HS, Byun KH, Jang JJ, Lee YS, Lim IK. Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma. Mol Carcinog. 2001;30:138-150. [PMID: 11301474 DOI: 10.1002/mc.1022] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Qin JM, Fu XY, Li SJ, Liu SQ, Zeng JZ, Qiu XH, Wu MC, Wang HY. Gene and protein expressions of p28GANK in rat with liver regeneration. World J Gastroenterol 2003; 9(11): 2523-2527 [PMID: 14606089 DOI: 10.3748/wjg.v9.i11.2523] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
2 Abe M, Okochi E, Kuramoto T, Kaneda A, Takato T, Sugimura T, Ushijima T. Cloning of the 5' upstream region of the rat p16 gene and its role in silencing. Jpn J Cancer Res 2002;93:1100-6. [PMID: 12417039 DOI: 10.1111/j.1349-7006.2002.tb01211.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
3 Pogribny IP, Rusyn I, Beland FA. Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents. Environ Mol Mutagen 2008;49:9-15. [PMID: 17879298 DOI: 10.1002/em.20342] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
4 M G MS, Chikhale R, Nanaware PP, Dalvi S, Venkatraman P. A druggable pocket on PSMD10Gankyrin that can accommodate an interface peptide and doxorubicin. Eur J Pharmacol 2022;915:174718. [PMID: 34953804 DOI: 10.1016/j.ejphar.2021.174718] [Reference Citation Analysis]
5 Lim IK. Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats. Mech Ageing Dev 2002;123:1665-80. [PMID: 12470904 DOI: 10.1016/s0047-6374(02)00087-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pogribny IP, James S. De novo methylation of the p16INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats. Cancer Letters 2002;187:69-75. [DOI: 10.1016/s0304-3835(02)00408-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
7 Umemura A, Itoh Y, Itoh K, Yamaguchi K, Nakajima T, Higashitsuji H, Onoue H, Fukumoto M, Okanoue T, Fujita J. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology. 2008;47:493-502. [PMID: 18161051 DOI: 10.1002/hep.22027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
8 Mizesko MC, Grewe C, Grabner A, Miller MS. Alterations at the Ink4a locus in transplacentally induced murine lung tumors. Cancer Lett 2001;172:59-66. [PMID: 11595130 DOI: 10.1016/s0304-3835(01)00647-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Li H, Fu X, Chen Y, Hong Y, Tan Y, Cao H, Wu M, Wang H. Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma. Gastroenterology. 2005;128:2029-2041. [PMID: 15940635 DOI: 10.1053/j.gastro.2005.03.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
10 Sreepriya M, Bali G. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia 2005;76:549-55. [PMID: 16009505 DOI: 10.1016/j.fitote.2005.04.014] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
11 Yuan C, Li J, Mahajan A, Poi MJ, Byeon IJ, Tsai MD. Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship. Biochemistry 2004;43:12152-61. [PMID: 15379554 DOI: 10.1021/bi049116o] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
12 Shan YF, Zhou WP, Fu XY, Yan HX, Yang W, Liu SQ, Cao HF, Kang B, Wu MC, Wang HY. The role of p28GANK in rat oval cells activation and proliferation. Liver Int 2006;26:240-7. [PMID: 16448463 DOI: 10.1111/j.1478-3231.2005.01203.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
13 Taheri T, Jamialahmadi K, Khadijeh F. Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell Lines. Asian Pac J Cancer Prev 2017;18:3413-8. [PMID: 29286612 DOI: 10.22034/APJCP.2017.18.12.3413] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Xiao J, Chen HS. Biological functions of melanoma-associated antigens. World J Gastroenterol 2004; 10(13): 1849-1853 [PMID: 15222021 DOI: 10.3748/wjg.v10.i13.1849] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
15 Lim IK. Spectrum of molecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fisher 344 male rats [Mechanisms of Ageing and Development 123 (2002) 1665-1680]. Mech Ageing Dev 2003;124:697-708. [PMID: 12825548 DOI: 10.1016/s0047-6374(03)00010-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
16 Ranasinghe KNK, Premarathna AD, Mahakapuge TAN, Wijesundera KK, Ambagaspitiya AT, Jayasooriya AP, Kularatne SAM, Rajapakse RPVJ. In vivo anticancer effects of Momordica charantia seed fat on hepatocellular carcinoma in a rat model. J Ayurveda Integr Med 2021;12:435-42. [PMID: 34275705 DOI: 10.1016/j.jaim.2021.03.001] [Reference Citation Analysis]
17 Huang KW, Huang YC, Tai KF, Chen BH, Lee PH, Hwang LH. Dual therapeutic effects of interferon-alpha gene therapy in a rat hepatocellular carcinoma model with liver cirrhosis. Mol Ther 2008;16:1681-7. [PMID: 18665156 DOI: 10.1038/mt.2008.160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
18 Li J, Guo Y. Gankyrin Oncoprotein: Structure, Function, and Involvement in Cancer. Curr Chem Biol 2010;4:13-9. [PMID: 32775187 DOI: 10.2174/2212796811004010013] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Iakova P, Timchenko L, Timchenko NA. Intracellular signaling and hepatocellular carcinoma. Semin Cancer Biol. 2011;21:28-34. [PMID: 20850540 DOI: 10.1016/j.semcancer.2010.09.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]
20 Zhao X, Fu J, Xu A, Yu L, Zhu J, Dai R, Su B, Luo T, Li N, Qin W, Wang B, Jiang J, Li S, Chen Y, Wang H. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. Cell Death Dis 2015;6:e1751. [PMID: 25950481 DOI: 10.1038/cddis.2015.120] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
21 Huang SJ, Cheng CL, Chen JR, Gong HY, Liu W, Wu JL. Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation. Biochem Biophys Res Commun 2017;490:1052-8. [PMID: 28668389 DOI: 10.1016/j.bbrc.2017.06.164] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
22 Kim SY, Hur W, Choi JE, Kim D, Wang JS, Yoon HY, Piao LS, Yoon SK. Functional characterization of human oncoprotein gankyrin in Zebrafish. Exp Mol Med 2009;41:8-16. [PMID: 19287195 DOI: 10.3858/emm.2009.41.1.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
23 Li X, Zhang Y, Xiong C, Jin H, Jing B, Zhang Y, Fan D. Overexpression of a new gene P28GANK confers multidrug resistance of gastric cancer cells. Cancer Invest 2009;27:129-39. [PMID: 19235584 DOI: 10.1080/07357900802189816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
24 Reed C, Hutcheson J, Mayhew CN, Witkiewicz AK, Knudsen ES. RB tumor suppressive function in response to xenobiotic hepatocarcinogens. Am J Pathol 2014;184:1853-9. [PMID: 24726645 DOI: 10.1016/j.ajpath.2014.02.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
25 Wang G, Rong J, Zhou Z, Duo J. A novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2, and bax in osteosarcoma cells. Mol Biol 2010;44:898-906. [DOI: 10.1134/s0026893310060063] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
26 Qin Y, Liu JY, Li B, Sun ZL, Sun ZF. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis. World J Gastroenterol 2004; 10(9): 1276-1280 [PMID: 15112341 DOI: 10.3748/wjg.v10.i9.1276] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
27 Krzywda S, Brzozowski AM, Higashitsuji H, Fujita J, Welchman R, Dawson S, Mayer RJ, Wilkinson AJ. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. J Biol Chem. 2004;279:1541-1545. [PMID: 14573599 DOI: 10.1074/jbc.m310265200] [Cited by in Crossref: 65] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
28 Jing H, Zhang G, Meng L, Meng Q, Mo H, Tai Y. Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance. Sci Rep 2014;4:5503. [PMID: 24999092 DOI: 10.1038/srep05503] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
29 Fu X, Tan L, Liu S, Li H, Chen L, Qin J, Wu M, Wang H. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics. J Cancer Res Clin Oncol 2004;130:514-20. [PMID: 15221469 DOI: 10.1007/s00432-004-0562-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
30 Sakurai T, Itoh K, Higashitsuji H, Nagao T, Nonoguchi K, Chiba T, Fujita J. A Cleaved Form of MAGE-A4 Binds to Miz-1 and Induces Apoptosis in Human Cells. Journal of Biological Chemistry 2004;279:15505-14. [DOI: 10.1074/jbc.m310437200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
31 Nitta RT, Smith CL, Kennedy BK. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2. PLoS One 2007;2:e963. [PMID: 17896003 DOI: 10.1371/journal.pone.0000963] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
32 Higashitsuji H, Higashitsuji H, Itoh K, Sakurai T, Nagao T, Sumitomo Y, Masuda T, Dawson S, Shimada Y, Mayer RJ. The oncoproteingankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell. 2005;8:75-87. [PMID: 16023600 DOI: 10.1016/j.ccr.2005.06.006] [Cited by in Crossref: 150] [Cited by in F6Publishing: 152] [Article Influence: 8.8] [Reference Citation Analysis]
33 Muscarella P, Bloomston M, Brewer AR, Mahajan A, Frankel WL, Ellison EC, Farrar WB, Weghorst CM, Li J. Expression of the p16INK4A/Cdkn2a gene is prevalently downregulated in human pheochromocytoma tumor specimens. Gene Expr 2008;14:207-16. [PMID: 19110720 DOI: 10.3727/105221608786883825] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
34 Pogribny IP, Beland FA. DNA methylome alterations in chemical carcinogenesis. Cancer Lett 2013;334:39-45. [PMID: 23010082 DOI: 10.1016/j.canlet.2012.09.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
35 Ni Y, Wang H, Chen F, Li J, DeKeyzer F, Feng Y, Yu J, Bosmans H, Marchal G. Tumor models and specific contrast agents for small animal imaging in oncology. Methods. 2009;48:125-138. [PMID: 19328231 DOI: 10.1016/j.ymeth.2009.03.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
36 Li J, Poi MJ, Tsai MD. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry. 2011;50:5566-5582. [PMID: 21619050 DOI: 10.1021/bi200642e] [Cited by in Crossref: 161] [Cited by in F6Publishing: 147] [Article Influence: 14.6] [Reference Citation Analysis]
37 Kim YH, Kim JH, Choi YW, Lim SK, Yim H, Kang SY, Chung YS, Lee GY, Park TJ. Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression. Exp Mol Pathol 2013;94:360-5. [PMID: 23276718 DOI: 10.1016/j.yexmp.2012.12.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
38 Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, da Silva TC, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. Cancers (Basel) 2021;13:5583. [PMID: 34771745 DOI: 10.3390/cancers13215583] [Reference Citation Analysis]
39 Dawson S, Apcher S, Mee M, Higashitsuji H, Baker R, Uhle S, Dubiel W, Fujita J, Mayer RJ. Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome. J Biol Chem. 2002;277:10893-10902. [PMID: 11779854 DOI: 10.1074/jbc.m107313200] [Cited by in Crossref: 84] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
40 Sreepriya M, Bali G. Effects of administration of Embelin and Curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/Phenobarbital-induced hepatocarcinogenesis in Wistar rats. Mol Cell Biochem 2006;284:49-55. [DOI: 10.1007/s11010-005-9012-7] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
41 Pei T, Li Y, Wang J, Wang H, Liang Y, Shi H, Sun B, Yin D, Sun J, Song R. YAP is a critical oncogene in human cholangiocarcinoma. Oncotarget. 2015;6:17206-17220. [PMID: 26015398 DOI: 10.18632/oncotarget.4043] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 13.2] [Reference Citation Analysis]
42 Her GM, Hsu CC, Hong JR, Lai CY, Hsu MC, Pang HW, Chan SK, Pai WY. Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta. 2011;1811:536-548. [PMID: 21722753 DOI: 10.1016/j.bbalip.2011.06.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
43 Song X, Wang J, Zheng T, Song R, Liang Y, Bhatta N, Yin D, Pan S, Liu J, Jiang H, Liu L. LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway. Mol Cancer. 2013;12:114. [PMID: 24093956 DOI: 10.1186/1476-4598-12-114] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
44 Zohny SF, Mahmoud AH, Borai IH, Bayoumi FS, Eissa E. Chemopreventive and therapeutic efficacy of Salsola inermis extract against N-nitrosodiethylamine-initiated and phenobarbital-promoted hepatocellular carcinogenesis in Wistar rats. Biomedicine & Aging Pathology 2013;3:229-34. [DOI: 10.1016/j.biomag.2013.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Fujita J, Sakurai T. The Oncoprotein Gankyrin/PSMD10 as a Target of Cancer Therapy. Adv Exp Med Biol 2019;1164:63-71. [PMID: 31576540 DOI: 10.1007/978-3-030-22254-3_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]